Pharma/Life Sciences
Europe Guide 2024 : France
Band 1
Email address
[email protected]Contact number
+33 1 4268 4800About
Provided by Dentons
At the forefront of scientific developments and ethical issues in the life sciences and healthcare fields, Dentons’ Life Sciences team in Paris provides its clients with global capabilities in the respective legal environment. With a business-friendly approach, our lawyers assist clients with resolving global, local and industry-specific life sciences and healthcare related issues.
Partners Jean-Marc Grosperrin, Olivia Guéguen, Anne-Laure Marcerou, Julien Le Guyader and their team, work closely with the other Dentons’ Life Sciences professionals at a worldwide level on cross-border projects. They are know to be one of the most proactive and responsive teams in the market.
Areas of expertise
- M&A and Private Equity
- Corporate and Transactional work
- Regulatory and Market Access
- French and EU Competition, Distribution and Antitrust
- Employment
- Intellectual Property and Technology
- Taxation
- Compliance
- Licensing
- Anti-gift Law
- Product Liability
- Clinical trial
- Litigation and Arbitration
Chambers Review
Dentons is an exceptional firm assisting life sciences clients with a variety of corporate, financing, regulatory and IP mandates. The team often handles M&A transactions and corporate reorganisations, and acts on cross-border matters across various European jurisdictions. The law firm boasts an impressive client roster of pharmaceutical companies as well as businesses from the technology sector.
Work Highlights
- Dentons advised Pfizer on its acquisition of Global Blood Therapeutic France’s distribution activities of Oxbryta, a treatment for sickle cell anaemia.
Strengths
Provided by Chambers
"Dentons has a very strong capability to advise quickly and handle complex situations with a very reactive team."
"The firm has a large team and network with many available experts and broad expertise."
"Dentons' wide network helps to have answers quickly in every country. This is a key element for international cross-border transactions. The team also has a strong knowledge of the pharmaceutical sector."
"Dentons has a very strong capability to advise quickly and handle complex situations with a very reactive team."
"The firm has a large team and network with many available experts and broad expertise."
"Dentons' wide network helps to have answers quickly in every country. This is a key element for international cross-border transactions. The team also has a strong knowledge of the pharmaceutical sector."
Notable Practitioners
Jean-Marc Grosperrin boasts a leading corporate practice, advising pharmaceutical companies on commercial agreements and acquisitions.
"Jean-Marc is an exceptional lawyer with strong business acumen. He is able to explain any complex topics in a very pedagogical way, he is very pragmatic. It is a pleasure to work with him especially on sensitive topics."
"I have been working with Jean-Marc for years and I have always had complete confidence and trust he could handle all matters."
"Jean-Marc Grosperrin is a good listener, available, extremely responsive and always finds appropriate solutions to complex legal issues."
Ranked Lawyers at
Dentons
France
Members
Provided by Dentons
Clients
Provided by Dentons
Abenex
Boiron
Bpi France
Dentsply Sirona
Essling Capital
Gilead
HRA Pharma
IPSEN
Imcheck Therapeutics
Kyowa Kirin Pharma
Lactalis
Medday Pharmaceuticals
Microport
Orion Corporation
Pfizer
Recordati
Servier
Verdoso
Industries
Provided by Dentons
Academic research centers
Biology labs, pharmacies groups, hospitals purchasing groups
Healthcare groups, including public and private hospitals, clinics, dialysis centers, special care units, nursing homes
Medical research institutes and foundations
Players in the medical devices, veterinary products, cosmetics, nutraceuticals, consumer health products, detergents, biocides, pesticides, food
Players in the pharmaceutical (princeps, generics, biosimilars, orphan drugs) and biotechnology industries
Service providers in the healthcare sector (e.g. CROs, CMOs)